Aifu Lin

6.7k citations
85 papers · 3.3k indexed · 1 hit paper · h-index 32

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
  • Immunology top 5%
    • Aquaculture disease management and microbiota
    • interferon and immune responses

Papers in

    • Cancer-related molecular mechanisms research 25
    • interferon and immune responses 11
    • Immune Cell Function and Interaction 11
    • T-cell and B-cell Immunology 9
    • Immune Response and Inflammation 8
    • Aquaculture disease management and microbiota 8

Aifu Lin

83 papers receiving 3.3k citations

Hit Papers

AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells 2021 · 334 citations
3342021202620222024100200300

Peers

Aifu Lin
Comparison fields: 5 of 114
  • Cancer Research 1.4k
  • Immunology 843
  • Molecular Biology 2.1k
  • Infectious Diseases 341
  • Cell Biology 260
Replace Nicolas Bidère with:
Nicolas Bidère France
Lahiru Gangoda Australia
Pengyan Xia China
Matthew Staron United States
Aude De Gassart France
Abul Bashar Mir Md. Khademul Islam Bangladesh
Mohashin Pathan Australia
Fumiyo Ikeda Japan
Ulrich Pannicke Germany
Todd W. Ridky United States
Aifu Lin relative to Nicolas Bidère France Nicolas Bidère's profile →
Citations per field
00.5×4.5×
Nicolas Bidère · 1×
Citations per year

Countries citing papers authored by Aifu Lin

Since Specialization
Citations

This map shows the geographic impact of Aifu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aifu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aifu Lin more than expected).

Fields of papers citing papers by Aifu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aifu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aifu Lin. The network helps show where Aifu Lin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Aifu Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aifu Lin Line = papers co-authored together Aifu Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20244
3 202414
4 20240
5 20245
6 202415
7 202334
8 20231
9 20235
10 20217
11 202042
12 202040
13 2018145
14 2017246
15 2014108
16 200988
17 19942
18 19942
19 19941
20 19941

About Aifu Lin

Aifu Lin is a scholar working on Cancer Research, Immunology, Cell Biology, Molecular Biology and Aging, having authored 85 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (25 papers), RNA modifications and cancer (14 papers), interferon and immune responses (11 papers), Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (9 papers), RNA Research and Splicing (9 papers), Immune Response and Inflammation (8 papers) and Aquaculture disease management and microbiota (8 papers). The work is most often cited by research in Cancer Research (1.4k citations), Immunology (843 citations), Molecular Biology (2.1k citations), Infectious Diseases (341 citations) and Cell Biology (260 citations). Aifu Lin has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Li‐xin Xiang, Jian-zhong Shao, Tong Shao, Dongdong Fan, Yanxiu Ma, Lei Qu, Shouyu Wang, Chunru Lin, Chunlai Li and Zhen Xing. Their work appears in journals such as Journal of Zhejiang University SCIENCE B, The Journal of Immunology, Journal of Investigative Dermatology, Frontiers in Immunology and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026